VerbatimParliament, as it happens

NHS: Drugs

Asked by Kit MalthouseConservativeDepartment of Health and Social CareTabled Answered 20 June 2025UIN 59051

The question

To ask the Secretary of State for Health and Social Care, whether his Department plans to align medicines spending growth with NHS budget growth in real terms.

Answered by Karin Smyth

The allowed rate of growth for branded medicines is established by the 2024 Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG).

The VPAG plays an important role in delivering improved health gains from medicines in the National Health Service across the United Kingdom, by securing rapid access to new medicines, supporting economic growth, and contributing to a financially sustainable health service.

We are taking decisive action to review the scheme to unlock innovation and drive investment in the UK's world-class pharmaceutical sector.

This review is ongoing, demonstrating our commitment to creating an environment where this innovative sector can thrive.

Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →

Open this question in Verbatim →

Every written question, searchable

155,000 questions tabled since the election, with the answer each department gave — and the ones still unanswered, with the clock running. Free to search.

Search written questions →Read on Verbatim